Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model

Shunsuke Shibao, Noriaki Minami, Naoyoshi Koike, Nobuyuki Fukui, Kazunari Yoshida, Hideyuki Saya, Oltea Sampetrean

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background. Glioblastomas have been shown to rely on glycolysis as an energy source. However, recent evidence suggests that at least a subset of glioma cells with stem cell-like properties can thrive on oxidative phosphorylation. It remains unclear whether both metabolic phenotypes support tumor propagation, if they are independent, and how stable they are. The present study investigated these questions with the use of isogenic murine glioma stem cells (GSCs). Methods. GSCs were established from tumors formed by Ink4a/Arf-null, H-RasV12-expressing glioma-initiating cells that differed in extracellular acidification potential. Metabolic characteristics of GSCs were determined by measurement of glucose, oxygen, and glutamine uptake, ATP content, and lactate production. Effects of metabolic inhibitors and changes in oxygen or nutrient availability on lactate production and tumorsphere growth were also determined. Results. GSCs were found either to consume more glucose and produce more lactate or to consume more oxygen and maintain a higher ATP content depending on the metabolic characteristics of the tumor cells of origin. The latter, mitochondrial-type GSCs increased lactate production after treatment with the oxidative phosphorylation inhibitor oligomycin or phenformin. Exposure to hypoxia also increased lactate production and expression of glycolysis-related enzymes and metabolites in mitochondrial-type GSCs in a reversible manner. Conclusions. Both glycolytic and mitochondrial-type energy production can sustain tumor propagation by isogenic GSCs. Whereas both phenotypes can be independent and stable, cells that rely on oxidative phosphorylation can also switch to a more glycolytic phenotype in response to metabolic stress, suggesting that plasticity is a further characteristic of GSC metabolism.

Original languageEnglish
Pages (from-to)343-354
Number of pages12
JournalNeuro-Oncology
Volume20
Issue number3
DOIs
Publication statusPublished - 2018 Feb 19

Fingerprint

Glioblastoma
Glioma
Stem Cells
Lactic Acid
Oxidative Phosphorylation
Glycolysis
Oxygen
Phenotype
Neoplasms
Adenosine Triphosphate
Phenformin
Oligomycins
Glucose
Physiological Stress
Glutamine
Food
Enzymes

Keywords

  • glioma stem cell
  • hypoxia
  • metabolic heterogeneity
  • metabolic plasticity

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model. / Shibao, Shunsuke; Minami, Noriaki; Koike, Naoyoshi; Fukui, Nobuyuki; Yoshida, Kazunari; Saya, Hideyuki; Sampetrean, Oltea.

In: Neuro-Oncology, Vol. 20, No. 3, 19.02.2018, p. 343-354.

Research output: Contribution to journalArticle

@article{35c0fd1f15f84124b2e5cac65726d4c7,
title = "Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model",
abstract = "Background. Glioblastomas have been shown to rely on glycolysis as an energy source. However, recent evidence suggests that at least a subset of glioma cells with stem cell-like properties can thrive on oxidative phosphorylation. It remains unclear whether both metabolic phenotypes support tumor propagation, if they are independent, and how stable they are. The present study investigated these questions with the use of isogenic murine glioma stem cells (GSCs). Methods. GSCs were established from tumors formed by Ink4a/Arf-null, H-RasV12-expressing glioma-initiating cells that differed in extracellular acidification potential. Metabolic characteristics of GSCs were determined by measurement of glucose, oxygen, and glutamine uptake, ATP content, and lactate production. Effects of metabolic inhibitors and changes in oxygen or nutrient availability on lactate production and tumorsphere growth were also determined. Results. GSCs were found either to consume more glucose and produce more lactate or to consume more oxygen and maintain a higher ATP content depending on the metabolic characteristics of the tumor cells of origin. The latter, mitochondrial-type GSCs increased lactate production after treatment with the oxidative phosphorylation inhibitor oligomycin or phenformin. Exposure to hypoxia also increased lactate production and expression of glycolysis-related enzymes and metabolites in mitochondrial-type GSCs in a reversible manner. Conclusions. Both glycolytic and mitochondrial-type energy production can sustain tumor propagation by isogenic GSCs. Whereas both phenotypes can be independent and stable, cells that rely on oxidative phosphorylation can also switch to a more glycolytic phenotype in response to metabolic stress, suggesting that plasticity is a further characteristic of GSC metabolism.",
keywords = "glioma stem cell, hypoxia, metabolic heterogeneity, metabolic plasticity",
author = "Shunsuke Shibao and Noriaki Minami and Naoyoshi Koike and Nobuyuki Fukui and Kazunari Yoshida and Hideyuki Saya and Oltea Sampetrean",
year = "2018",
month = "2",
day = "19",
doi = "10.1093/neuonc/nox170",
language = "English",
volume = "20",
pages = "343--354",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model

AU - Shibao, Shunsuke

AU - Minami, Noriaki

AU - Koike, Naoyoshi

AU - Fukui, Nobuyuki

AU - Yoshida, Kazunari

AU - Saya, Hideyuki

AU - Sampetrean, Oltea

PY - 2018/2/19

Y1 - 2018/2/19

N2 - Background. Glioblastomas have been shown to rely on glycolysis as an energy source. However, recent evidence suggests that at least a subset of glioma cells with stem cell-like properties can thrive on oxidative phosphorylation. It remains unclear whether both metabolic phenotypes support tumor propagation, if they are independent, and how stable they are. The present study investigated these questions with the use of isogenic murine glioma stem cells (GSCs). Methods. GSCs were established from tumors formed by Ink4a/Arf-null, H-RasV12-expressing glioma-initiating cells that differed in extracellular acidification potential. Metabolic characteristics of GSCs were determined by measurement of glucose, oxygen, and glutamine uptake, ATP content, and lactate production. Effects of metabolic inhibitors and changes in oxygen or nutrient availability on lactate production and tumorsphere growth were also determined. Results. GSCs were found either to consume more glucose and produce more lactate or to consume more oxygen and maintain a higher ATP content depending on the metabolic characteristics of the tumor cells of origin. The latter, mitochondrial-type GSCs increased lactate production after treatment with the oxidative phosphorylation inhibitor oligomycin or phenformin. Exposure to hypoxia also increased lactate production and expression of glycolysis-related enzymes and metabolites in mitochondrial-type GSCs in a reversible manner. Conclusions. Both glycolytic and mitochondrial-type energy production can sustain tumor propagation by isogenic GSCs. Whereas both phenotypes can be independent and stable, cells that rely on oxidative phosphorylation can also switch to a more glycolytic phenotype in response to metabolic stress, suggesting that plasticity is a further characteristic of GSC metabolism.

AB - Background. Glioblastomas have been shown to rely on glycolysis as an energy source. However, recent evidence suggests that at least a subset of glioma cells with stem cell-like properties can thrive on oxidative phosphorylation. It remains unclear whether both metabolic phenotypes support tumor propagation, if they are independent, and how stable they are. The present study investigated these questions with the use of isogenic murine glioma stem cells (GSCs). Methods. GSCs were established from tumors formed by Ink4a/Arf-null, H-RasV12-expressing glioma-initiating cells that differed in extracellular acidification potential. Metabolic characteristics of GSCs were determined by measurement of glucose, oxygen, and glutamine uptake, ATP content, and lactate production. Effects of metabolic inhibitors and changes in oxygen or nutrient availability on lactate production and tumorsphere growth were also determined. Results. GSCs were found either to consume more glucose and produce more lactate or to consume more oxygen and maintain a higher ATP content depending on the metabolic characteristics of the tumor cells of origin. The latter, mitochondrial-type GSCs increased lactate production after treatment with the oxidative phosphorylation inhibitor oligomycin or phenformin. Exposure to hypoxia also increased lactate production and expression of glycolysis-related enzymes and metabolites in mitochondrial-type GSCs in a reversible manner. Conclusions. Both glycolytic and mitochondrial-type energy production can sustain tumor propagation by isogenic GSCs. Whereas both phenotypes can be independent and stable, cells that rely on oxidative phosphorylation can also switch to a more glycolytic phenotype in response to metabolic stress, suggesting that plasticity is a further characteristic of GSC metabolism.

KW - glioma stem cell

KW - hypoxia

KW - metabolic heterogeneity

KW - metabolic plasticity

UR - http://www.scopus.com/inward/record.url?scp=85042280660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042280660&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nox170

DO - 10.1093/neuonc/nox170

M3 - Article

VL - 20

SP - 343

EP - 354

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 3

ER -